Table 4. Response Outcomes With Modified Hyper-CVAD Versus Standard Hyper-CVAD.
Response | Modified Hyper-CVAD, n = 68, % | Hyper-CVAD, n = 208, % | P |
---|---|---|---|
CR | |||
Overall | 93 | 95 | NS |
After course 1 | 78 | 77 | |
CR with incomplete platelet recovery | 1 | 0 | |
Partial response | 4 | 0 | NS |
Resistant disease | 0 | 2 | NS |
Induction mortality | 1 | 3 | NS |
Hyper-CVAD indicates fractionated cyclophosphamide, vincristine, doxoru-bicin, and dexamethasone; CR, complete response; NS, not significant.